Summary
CVS Health Corporation (CVS), filed an 8-K report on February 5, 2008, detailing an amendment to its by-laws. The primary focus of this filing is the addition of a new Article VI, Section 8 to the Company's by-laws. This amendment establishes specific terms and conditions under which the Board of Directors can amend a stockholder rights plan (commonly known as a 'poison pill') or similar anti-takeover devices, particularly concerning the extension of their terms beyond one year. It is important to note for investors that at the time of this filing, CVS Caremark Corporation did not have such a stockholder rights plan or anti-takeover device in place. This amendment outlines the procedural requirements should the company decide to implement or modify such a plan in the future. The filing also includes the Amended and Restated By-laws as an exhibit.
Key Highlights
- 1CVS Caremark Corporation (CVS) filed an 8-K on February 5, 2008, reporting an amendment to its by-laws.
- 2A new by-law (Article VI, Section 8) has been added, governing amendments to stockholder rights plans ('poison pills').
- 3The amendment specifies conditions for the Board to amend a poison pill, particularly if extending its term beyond one year.
- 4The company explicitly states that it does not currently have a stockholder rights plan or similar anti-takeover device in effect.
- 5This by-law change provides a framework for future board actions regarding anti-takeover measures.
- 6The Amended and Restated By-laws, effective February 5, 2008, were filed as an exhibit to the 8-K.